Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease

Piero O. Bonetti, Gregory W. Barsness, Paul C. Keelan, Theresa I. Schnell, Geralyn M. Pumper, Jeffrey T. Kuvin, Robert P. Schnall, David Holmes, Stuart T. Higano, Amir Lerman

Research output: Contribution to journalArticle

305 Citations (Scopus)

Abstract

OBJECTIVES: The goal of this study was to examine the effect of enhanced external counterpulsation (EECP) on endothelial function. BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). However, the exact mechanisms by which this technique exerts its clinical benefit are unclear. METHODS: Reactive hyperemia-peripheral arterial tonometry (RH-PAT), a noninvasive method to assess peripheral endothelial function by measuring reactive hyperemic response in the finger, was performed in 23 patients with refractory angina undergoing a 35-h course of EECP. In each patient RH-PAT measurements were performed before and after the first, at midcourse, and the last EECP session. In addition, RH-PAT response was assessed one month after completion of EECP therapy; RH-PAT index, a measure of reactive hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia divided by that at rest. RESULTS: Enhanced external counterpulsation led to symptomatic improvement (≥1 Canadian Cardiovascular Society class) in 17 (74%) patients; EECP was associated with a significant immediate increase in average RH-PAT index after each treatment (p < 0.05). In addition, average RH-PAT index at one-month follow-up was significantly higher than that before EECP therapy (p < 0.05). When patients were divided by their clinical response, RH-PAT index at one-month follow-up increased only in those patients who experienced clinical benefit. CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. This suggests that improvement in endothelial function may contribute to the clinical benefit of EECP in patients with symptomatic CAD.

Original languageEnglish (US)
Pages (from-to)1761-1768
Number of pages8
JournalJournal of the American College of Cardiology
Volume41
Issue number10
DOIs
StatePublished - May 21 2003

Fingerprint

Counterpulsation
Hyperemia
Coronary Artery Disease
Manometry
Exercise Tolerance
Fingers
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. / Bonetti, Piero O.; Barsness, Gregory W.; Keelan, Paul C.; Schnell, Theresa I.; Pumper, Geralyn M.; Kuvin, Jeffrey T.; Schnall, Robert P.; Holmes, David; Higano, Stuart T.; Lerman, Amir.

In: Journal of the American College of Cardiology, Vol. 41, No. 10, 21.05.2003, p. 1761-1768.

Research output: Contribution to journalArticle

Bonetti, Piero O. ; Barsness, Gregory W. ; Keelan, Paul C. ; Schnell, Theresa I. ; Pumper, Geralyn M. ; Kuvin, Jeffrey T. ; Schnall, Robert P. ; Holmes, David ; Higano, Stuart T. ; Lerman, Amir. / Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. In: Journal of the American College of Cardiology. 2003 ; Vol. 41, No. 10. pp. 1761-1768.
@article{9537834ff28d466699ef12217a22f9fe,
title = "Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease",
abstract = "OBJECTIVES: The goal of this study was to examine the effect of enhanced external counterpulsation (EECP) on endothelial function. BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). However, the exact mechanisms by which this technique exerts its clinical benefit are unclear. METHODS: Reactive hyperemia-peripheral arterial tonometry (RH-PAT), a noninvasive method to assess peripheral endothelial function by measuring reactive hyperemic response in the finger, was performed in 23 patients with refractory angina undergoing a 35-h course of EECP. In each patient RH-PAT measurements were performed before and after the first, at midcourse, and the last EECP session. In addition, RH-PAT response was assessed one month after completion of EECP therapy; RH-PAT index, a measure of reactive hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia divided by that at rest. RESULTS: Enhanced external counterpulsation led to symptomatic improvement (≥1 Canadian Cardiovascular Society class) in 17 (74{\%}) patients; EECP was associated with a significant immediate increase in average RH-PAT index after each treatment (p < 0.05). In addition, average RH-PAT index at one-month follow-up was significantly higher than that before EECP therapy (p < 0.05). When patients were divided by their clinical response, RH-PAT index at one-month follow-up increased only in those patients who experienced clinical benefit. CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. This suggests that improvement in endothelial function may contribute to the clinical benefit of EECP in patients with symptomatic CAD.",
author = "Bonetti, {Piero O.} and Barsness, {Gregory W.} and Keelan, {Paul C.} and Schnell, {Theresa I.} and Pumper, {Geralyn M.} and Kuvin, {Jeffrey T.} and Schnall, {Robert P.} and David Holmes and Higano, {Stuart T.} and Amir Lerman",
year = "2003",
month = "5",
day = "21",
doi = "10.1016/S0735-1097(03)00329-2",
language = "English (US)",
volume = "41",
pages = "1761--1768",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease

AU - Bonetti, Piero O.

AU - Barsness, Gregory W.

AU - Keelan, Paul C.

AU - Schnell, Theresa I.

AU - Pumper, Geralyn M.

AU - Kuvin, Jeffrey T.

AU - Schnall, Robert P.

AU - Holmes, David

AU - Higano, Stuart T.

AU - Lerman, Amir

PY - 2003/5/21

Y1 - 2003/5/21

N2 - OBJECTIVES: The goal of this study was to examine the effect of enhanced external counterpulsation (EECP) on endothelial function. BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). However, the exact mechanisms by which this technique exerts its clinical benefit are unclear. METHODS: Reactive hyperemia-peripheral arterial tonometry (RH-PAT), a noninvasive method to assess peripheral endothelial function by measuring reactive hyperemic response in the finger, was performed in 23 patients with refractory angina undergoing a 35-h course of EECP. In each patient RH-PAT measurements were performed before and after the first, at midcourse, and the last EECP session. In addition, RH-PAT response was assessed one month after completion of EECP therapy; RH-PAT index, a measure of reactive hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia divided by that at rest. RESULTS: Enhanced external counterpulsation led to symptomatic improvement (≥1 Canadian Cardiovascular Society class) in 17 (74%) patients; EECP was associated with a significant immediate increase in average RH-PAT index after each treatment (p < 0.05). In addition, average RH-PAT index at one-month follow-up was significantly higher than that before EECP therapy (p < 0.05). When patients were divided by their clinical response, RH-PAT index at one-month follow-up increased only in those patients who experienced clinical benefit. CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. This suggests that improvement in endothelial function may contribute to the clinical benefit of EECP in patients with symptomatic CAD.

AB - OBJECTIVES: The goal of this study was to examine the effect of enhanced external counterpulsation (EECP) on endothelial function. BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). However, the exact mechanisms by which this technique exerts its clinical benefit are unclear. METHODS: Reactive hyperemia-peripheral arterial tonometry (RH-PAT), a noninvasive method to assess peripheral endothelial function by measuring reactive hyperemic response in the finger, was performed in 23 patients with refractory angina undergoing a 35-h course of EECP. In each patient RH-PAT measurements were performed before and after the first, at midcourse, and the last EECP session. In addition, RH-PAT response was assessed one month after completion of EECP therapy; RH-PAT index, a measure of reactive hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia divided by that at rest. RESULTS: Enhanced external counterpulsation led to symptomatic improvement (≥1 Canadian Cardiovascular Society class) in 17 (74%) patients; EECP was associated with a significant immediate increase in average RH-PAT index after each treatment (p < 0.05). In addition, average RH-PAT index at one-month follow-up was significantly higher than that before EECP therapy (p < 0.05). When patients were divided by their clinical response, RH-PAT index at one-month follow-up increased only in those patients who experienced clinical benefit. CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. This suggests that improvement in endothelial function may contribute to the clinical benefit of EECP in patients with symptomatic CAD.

UR - http://www.scopus.com/inward/record.url?scp=0038239542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038239542&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(03)00329-2

DO - 10.1016/S0735-1097(03)00329-2

M3 - Article

C2 - 12767662

AN - SCOPUS:0038239542

VL - 41

SP - 1761

EP - 1768

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 10

ER -